遺伝子合成：各種技術および世界市場

世界の遺伝子合成の市場規模は、2023年の20億米ドルから、予測期間中は15.8%のCAGRで推移し、2028年には41億米ドルの規模に成長すると予測されています。

抗体DNA合成の部門は、2023年の12億米ドルから、同期間中は16.0%のCAGRで推移し、2028年には25億米ドルに達すると予測されています。ウイルスDNA合成の部門は、2023年の5億2,660万米ドルから、CAGR 16.2%で推移し、2028年には11億米ドルに達すると予測されています。

当レポートでは、世界の遺伝子合成の市場を調査し、市場概要、法規制環境、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 遺伝子合成の概要
• 遺伝子合成の手法
• 遺伝子合成の用途
• 遺伝子合成における科学的進歩
• 遺伝子合成における技術革新
• 遺伝子合成における倫理的考察
• 社会的影響

第3章 市場力学

• 概要
• 市場促進要因
• バイオ医薬品研究開発
• 診断および治療への応用
• 農業バイオテクノロジーの進歩
• DNAデータストレージと合成ゲノミクス
• 技術の進歩とコスト削減
• R&Dへの投資増加
• 個別化医療における機会
• 抑制要因
• コスト上の制約
• 品質管理と標準化の欠如
• 機会
• 個別化医療と精密医療
• 遺伝子合成におけるAI
• 課題
• 知的財産問題
• 長い処理時間

第4章 規制状況

• バイオセキュリティと二重使用の懸念
• 輸出管理と貿易規制
• 知的財産権
• 臨床応用の規制監督
• 倫理的および社会的考察
• 品質保証と製品基準
• 国別の規制上の課題
• 米国
• カナダ
• 欧州
• 日本
• インド
• ブラジル

第5章 新興技術と開発

• 酵素によるDNA合成
• マイクロ流体DNA合成
• 機械学習とAI
• TBIO (Thermodynamically Balanced Inside-out)
• リガーゼベースの遺伝子合成
• ポリメラーゼベースの遺伝子合成
• 特許分析

第6章 市場セグメンテーション分析

• セグメンテーションの内訳
• 遺伝子合成：世界市場
• 遺伝子合成の世界市場：手法別
• 固相合成
• PCRベース酵素合成
• チップベース合成
• 遺伝子合成の世界市場：サービス別
• 抗体DNA合成
• ウイルスDNA合成
• その他
• 遺伝子合成の世界市場：用途別
• 遺伝子・細胞治療の開発
• ワクチン開発
• 病気の診断
• その他
• 遺伝子合成の世界市場：エンドユーザー別
• 学術機関・政府研究機関
• バイオテクノロジー・製薬企業
• CRO
• 地理的内訳
• 社内かアウトソースか
• コストの考察
• 品質管理と保証
• 利便性と納期
• カスタマイズと特化
• 戦略的考察

第7章 競合情勢

• 企業ランキング
• M&Aとベンチャーファンディング
• サマリー

第8章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• AZENTA US INC.
• DANAHER CORP.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PROMAB BIOTECHNOLOGIES INC.
• PROTEOGENIX
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE

List of Tables

• Summary Table : Global Market for Gene Synthesis, by Services, Through 2028
• Table 1 : Patents Related to Gene Synthesis Market, by Owner, January 2023-March 2024
• Table 2 : Patents Related to Gene Synthesis Market, by Applicant, January 2023-March 2024
• Table 3 : Global Market for Gene Synthesis, Through 2028
• Table 4 : Global Market for Gene Synthesis, by Method, Through 2028
• Table 5 : Global Market for Solid-phase Synthesis, by Region, Through 2028
• Table 6 : Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
• Table 7 : Global Market for Chip-based Synthesis, by Region, Through 2028
• Table 8 : Global Market for Gene Synthesis, by Services, Through 2028
• Table 9 : Global Market for Antibody DNA Synthesis, by Region, Through 2028
• Table 10 : Global Market for Viral DNA Synthesis, by Region, Through 2028
• Table 11 : Global Market for Other Synthesis Services, by Region, Through 2028
• Table 12 : Global Market for Gene Synthesis, by Application, Through 2028
• Table 13 : Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
• Table 14 : Global Market for Vaccine Development Applications, by Region, Through 2028
• Table 15 : Global Market for Disease Diagnosis Applications, by Region, Through 2028
• Table 16 : Global Market for Other Applications, by Region, Through 2028
• Table 17 : Global Market for Gene Synthesis, by End User, Through 2028
• Table 18 : Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
• Table 19 : Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
• Table 20 : Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
• Table 21 : Ranking of Gene Synthesis Companies, 2022
• Table 22 : Mergers and Acquisitions (M&A), 2021-2023
• Table 23 : Venture Funding, 2022 and 2023
• Table 24 : Report Sources
• Table 25 : Abbreviations Used in the Report
• Table 26 : Azenta US Inc.: Company Snapshot
• Table 27 : Azenta US Inc.: Financial Performance, FY 2022 and 2023
• Table 28 : Azenta US Inc.: Product Portfolio
• Table 29 : Azenta US Inc.: News/Key Developments, 2021-2023
• Table 30 : Danaher Corp.: Company Snapshot
• Table 31 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 32 : Danaher Corp.: Product Portfolio
• Table 33 : Danaher Corp.: News/Key Developments, 2023
• Table 34 : Eurofins Scientific: Company Snapshot
• Table 35 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
• Table 36 : Eurofins Scientific: Product Portfolio
• Table 37 : GenScript: Company Snapshot
• Table 38 : GenScript: Financial Performance, FY 2021 and 2022
• Table 39 : GenScript: Product Portfolio
• Table 40 : GenScript: News/Key Developments, 2023
• Table 41 : Merck KgaA: Company Snapshot
• Table 42 : Merck KgaA: Financial Performance, FY 2022 and 2023
• Table 43 : Merck KgaA: Product Portfolio
• Table 44 : Merck KgaA: News/Key Developments, 2022
• Table 45 : OriGene Technologies Inc.: Company Snapshot
• Table 46 : OriGene Technologies Inc.: Product Portfolio
• Table 47 : OriGene Technologies Inc.: News/Key Developments, 2022
• Table 48 : ProMab: Company Snapshot
• Table 49 : ProMab: Product Portfolio
• Table 50 : ProteoGenix: Company Snapshot
• Table 51 : ProteoGenix: Product Portfolio
• Table 52 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 53 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 54 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 55 : Twist Bioscience: Company Snapshot
• Table 56 : Twist Bioscience: Financial Performance, FY 2022 and 2023
• Table 57 : Twist Bioscience: Product Portfolio

List of Figures

• Summary Figure : Global Market for Gene Synthesis, by Services, 2020-2028
• Figure 1 : Market Dynamics of Gene Synthesis
• Figure 2 : Global Market Shares for Gene Synthesis, by Method, 2022
• Figure 3 : Global Market Shares for Gene Synthesis, by Services, 2022
• Figure 4 : Global Market Shares for Gene Synthesis, by Application, 2022
• Figure 5 : Global Market Shares for Gene Synthesis, by End User, 2022
• Figure 6 : Azenta US Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 7 : Azenta US Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 8 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
• Figure 9 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
• Figure 10 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
• Figure 11 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
• Figure 12 : GenScript: Revenue Shares, by Business Unit, FY 2022
• Figure 13 : GenScript: Revenue Shares, by Country/Region, FY 2022
• Figure 14 : Merck KgaA: Revenue Shares, by Business Unit, FY 2023
• Figure 15 : Merck KgaA: Revenue Shares, by Country/Region, FY 2023
• Figure 16 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 17 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 18 : Twist Bioscience: Revenue Shares, by Business Unit, FY 2023
• Figure 19 : Twist Bioscience: Revenue Shares, by Country/Region, FY 2023

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

The Antibody DNA synthesis market for Gene Synthesis is estimated to increase from $1.2 billion in 2023 to reach $2.5 billion by 2028, at a CAGR of 16.0% from 2023 through 2028.

The Viral DNA synthesis market for Gene Synthesis is estimated to increase from $526.6 million in 2023 to reach $1.1 billion by 2028, at a CAGR of 16.2% from 2023 through 2028.

Report Scope

This report explores critical trends in the gene synthesis market, including the market drivers and restraints, R&D spending, increasing competition, new technologies, product launches and therapeutic applications. Merger and acquisition (M&A) activity and partnerships between companies are also discussed. In this report, the global market for gene synthesis is segmented by method, services, application, end user and region. Companies considering expanding their geographic reach will find the coverage of the regional markets helpful.

Report Includes

• 26 data tables and 32 additional tables
• An analysis of the global markets for gene synthesis
• A discussion of the global market trends, with current and historical market revenue (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• An evaluation of the market size and revenue forecast for the global gene synthesis market, and corresponding market share analysis by method, services, application, end user and region
• A look at the drivers and challenges that affect the global market
• An analysis of the emerging technologies and new developments in the gene synthesis market
• A discussion of ESG developments, including consumer attitudes, impact of ESG on company performance, analysis of companies' ESG scores and the future of ESG, and ESG practices of leading companies
• An analysis of the vendor landscape, including the company market shares, recent M&A activity and the outlook for venture funding
• Company profiles of major players within the industry, including GenScript, Eurofins Scientific, Thermo Fisher Scientific Inc., Merck KGaA, and Azenta US Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview of Gene Synthesis
• Gene Synthesis Methods
• Gene Synthesis Applications
• Scientific Advances in Gene Synthesis
• Technological Innovation in Gene Synthesis
• Ethical Considerations in Gene Synthesis
• Societal Implications

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Biopharmaceutical R&D
• Diagnostic and Therapeutic Applications
• Advances in Agrobiotechnology
• DNA Data Storage and Synthetic Genomics
• Advances and Cost Reductions in Technology
• Rising Investments in R&D
• Opportunities in Personalized Medicine
• Restraints
• Cost Constraints
• Lack of Quality Control and Standardization
• Opportunities
• Personalized Medicine and Precision Healthcare
• AI in Gene Synthesis
• Challenges
• Intellectual Property Issues
• Long Turnaround Times

Chapter 4 Regulatory Landscape

• Biosecurity and Dual-use Concerns
• Export Controls and Trade Regulations
• Intellectual Property Rights
• Regulatory Oversight of Clinical Applications
• Ethical and Societal Considerations
• Quality Assurance and Product Standards
• Regulatory Challenges by Country
• United States
• Canada
• Europe
• Japan
• India
• Brazil

Chapter 5 Emerging Technologies and Developments

• Enzymatic DNA Synthesis
• Microfluidic DNA Synthesis
• Machine Learning and AI
• Thermodynamically Balanced Inside-out
• Ligase-based Gene Synthesis
• Polymerase-based Gene Synthesis
• Patent Analysis

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Gene Synthesis: Global Market
• Global Market for Gene Synthesis, by Method
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis
• Global Market for Gene Synthesis, by Services
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Other Gene Synthesis Services
• Gene Synthesis: Global Markets, by Application
• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Other Applications
• Global Market for Gene Synthesis, by End User
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Geographic Breakdown
• In-house or Outsource?
• Cost Considerations
• Quality Control and Assurance
• Convenience and Turnaround Time
• Customization and Specialization
• Strategic Considerations

Chapter 7 Competitive Landscape

• Company Rankings
• M&A and Venture Funding
• In Summation

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AZENTA US INC.
• DANAHER CORP.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PROMAB BIOTECHNOLOGIES INC.
• PROTEOGENIX
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE